Historical record - last NADAC effective date: 1/8/2016

Product Information

CONZIP 200 MG CAPSULE is a brand product labeled by Vertical Pharmaceuticals, LLC, priced at $11.5216 per EA under NDC 68025007230. Its NADAC has been published 119 times since Oct 8, 2014.

FDA first approved this application on May 7, 2010.

The High Outlier badge above means this manufacturer's average price in the tramadol hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CONZIP 200 MG CAPSULE

tramadol hydrochloride
$11.5216per EA
High Outlier
DEA Schedule CIV

Strength

200 mg/1

NDC

68025007230

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

1/8/2016

Active Ingredients

TRAMADOL HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA022370

FDA Approved

5/7/2010

On Market Since

9/20/2011

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for CONZIP 200 MG CAPSULE has been published 119 times since Oct 8, 2014, and over the history we have for it it has risen 40.4%. The table below summarizes its recorded NADAC range and movement.

Current price$11.5216 per EA
All-time high$11.5216 (Jan 11, 2017)
All-time low$8.2056 (Oct 8, 2014)
Median price$11.1860
Average price$10.5562
Largest weekly change+25.0% (May 20, 2015)
Weeks tracked119
Tracking sinceOct 8, 2014

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+40.4%

Last surveyed Jan 11, 2017 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 19%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of CONZIP 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CONZIP 200 MG CAPSULE, manufactured by Vertical Pharmaceuticals, LLC, is $11.5216 per EA (NDC 68025007230), effective Jan 11, 2017.

How has the price of CONZIP 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CONZIP 200 MG CAPSULE has risen 40.4%. It has been tracked across 119 weekly CMS publications since Oct 8, 2014.

What are the highest and lowest recorded NADAC prices for CONZIP 200 MG CAPSULE?

Since Oct 8, 2014, the NADAC for CONZIP 200 MG CAPSULE has ranged from a low of $8.2056 (Oct 8, 2014) to a high of $11.5216 (Jan 11, 2017), with a median of $11.1860 per EA.

Are there cheaper alternatives to CONZIP 200 MG CAPSULE?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRAMADOL HCL ER 200 MG CAPSULE, is $9.3589 per EA — about 19% below CONZIP 200 MG CAPSULE.

Who manufactures CONZIP 200 MG CAPSULE?

CONZIP 200 MG CAPSULE (NDC 68025007230) is labeled by Vertical Pharmaceuticals, LLC, and CMS classifies it as a brand product.